The Food and Drug Administration has approved Geodon (Ziprasidone) as a maintenance treatment for bipolar I disorder. After a six month... Read more »
Today, the FDA approved Risperdal for the treatment of schizophrenia in adolescents 13 to 17 years old and for the short-term (three week)... Read more »
Almotriptan, better known as Axert and Almogran, is one of eight triptan medications developed to abort a Migraine attack in... Read more »
Geodon - generic name ziprasidone - is an antipsychotic medication. It's approved to treat bipolar I disorder and schizophrenia, but is... Read more »
The approval by the FDA for the use of Risperdal in the treatment of schizophrenia and bipolar disorder in children is a momentous event.... Read more »
The U.S. Food and Drug Administration (FDA) approved NEXIUM® delayed release capsules in children ages 12 to 17 for the short-term treatment of... Read more »
The U.S. Food and Drug Administration has approved Pfizer’s Geodon as an add-on treatment for bipolar disorder. The drug, which is already approved... Read more »
The U.S. Food and Drug Administration (FDA) has approved the first triptan medication to treat migraines in adolescents. The drug, called... Read more »
The U.S. Food and Drug Administration (FDA) has approved the first triptan medication to treat migraines in adolescents. The drug, called... Read more »
Source: ADAM Encyclopedia
Depression - adolescents; Teenage depressionTreatmentTreatment options for adolescents with depression include:Supportive care from a medical... Read more »